Manifestations and treatment of human parvovirus B19 infection in immunocompromised patients

We diagnosed infections from human parvovirus B19 in three patients by using dot-blot hybrodization and a polymerase chain reaction to detect B19 DNA and using an enzyme immunoassay to detect IgG and IgM to B19. For 5 months a 5-year-old boy with acute lymphoblastic leukemia in remission had anemia...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of pediatrics 1990-03, Vol.116 (3), p.355-359
Hauptverfasser: Koch, William C., Massey, Gita, Russell, Clifton E., Adler, Stuart P.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 359
container_issue 3
container_start_page 355
container_title The Journal of pediatrics
container_volume 116
creator Koch, William C.
Massey, Gita
Russell, Clifton E.
Adler, Stuart P.
description We diagnosed infections from human parvovirus B19 in three patients by using dot-blot hybrodization and a polymerase chain reaction to detect B19 DNA and using an enzyme immunoassay to detect IgG and IgM to B19. For 5 months a 5-year-old boy with acute lymphoblastic leukemia in remission had anemia without reticulocytes or bone marrow erythrocyte precursors. His serum lacked IgG and IgM to B19 but contained B19 DNA. He received gamma globulin intravenously (0.4 gm/kg/day for 5 days); his viremia promptly cleared and reticulocytosis developed. A 14-year-old boy with acute lymphoblastic leukemia in remission had fever, rash, neutropenia (
doi_str_mv 10.1016/S0022-3476(05)82820-3
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_79655273</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0022347605828203</els_id><sourcerecordid>79655273</sourcerecordid><originalsourceid>FETCH-LOGICAL-c412t-1fa57bc688a278b0c8596b57c9675cd99651f025bd54dd2bee1ccc1ac57ec0363</originalsourceid><addsrcrecordid>eNqFkE9LxDAQxYMo67r6ERZ6Ej1UJ2mTtCfRxX-w4kG9CSFNUoxsmzVpF_z2pttFj55mYN6befNDaI7hAgNmly8AhKRZztkZ0POCFATSbA9NMZQ8ZUWW7aPpr-QQHYXwCQBlDjBBE8yKkvN8it6fZGtrEzrZWdeGRLY66byRXWPaLnF18tE3sk3W0m_cxvo-JDe4TGxbGzUYYpfYpulbp1yz9q6xweio7my0h2N0UMtVMCe7OkNvd7evi4d0-Xz_uLhepirHpEtxLSmvFCsKSXhRgSpoySrKVck4VbosGcU1EFppmmtNKmOwUgpLRblRkLFshk7HvTHBVx-fETGHMquVbI3rg-BxAyU8i0I6CpV3IXhTi7W3jfTfAoMYqIotVTEgE0DFlqoYfPPdgb5qjP5zjRjj_Gqcm_jlxhovgooElNHWR1BCO_vPhR-G8Iiz</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>79655273</pqid></control><display><type>article</type><title>Manifestations and treatment of human parvovirus B19 infection in immunocompromised patients</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Koch, William C. ; Massey, Gita ; Russell, Clifton E. ; Adler, Stuart P.</creator><creatorcontrib>Koch, William C. ; Massey, Gita ; Russell, Clifton E. ; Adler, Stuart P.</creatorcontrib><description>We diagnosed infections from human parvovirus B19 in three patients by using dot-blot hybrodization and a polymerase chain reaction to detect B19 DNA and using an enzyme immunoassay to detect IgG and IgM to B19. For 5 months a 5-year-old boy with acute lymphoblastic leukemia in remission had anemia without reticulocytes or bone marrow erythrocyte precursors. His serum lacked IgG and IgM to B19 but contained B19 DNA. He received gamma globulin intravenously (0.4 gm/kg/day for 5 days); his viremia promptly cleared and reticulocytosis developed. A 14-year-old boy with acute lymphoblastic leukemia in remission had fever, rash, neutropenia (&lt;300 leukocytes/mm 3), and a hemophagocytic syndrome lasting 3 weeks. His serum contained IgM to B19 and B19 DNA. Without therapy, IgG to B19 developed; although low levels of B19 DNA persisted, the leukocyte count returned to normal. In a 19-year-old patient with systemic lupus erythrmatosus and hemolytic anemia, an aplastic crisis lasted 2 weeks. Her serum lacked IgG and IgM to B19 but contained B19 DNA. Without therapy, IgG and IgM to B19 appeared, viremia diminished, and reticulocytosis occurred. These patients illustrate the varied manifestations of chronic B19 infections, the importance of DNA detection for diagnosis, and the possible efficacy of gamma globulin therapy</description><identifier>ISSN: 0022-3476</identifier><identifier>EISSN: 1097-6833</identifier><identifier>DOI: 10.1016/S0022-3476(05)82820-3</identifier><identifier>PMID: 1689774</identifier><language>eng</language><publisher>United States: Mosby, Inc</publisher><subject>Adolescent ; Adult ; Child, Preschool ; DNA, Viral - analysis ; Female ; gamma-Globulins - therapeutic use ; Humans ; Immune Tolerance ; Immunoenzyme Techniques ; Lupus Erythematosus, Systemic - complications ; Male ; Parvoviridae Infections - diagnosis ; Parvoviridae Infections - etiology ; Parvoviridae Infections - immunology ; Parvoviridae Infections - therapy ; Polymerase Chain Reaction ; Precursor Cell Lymphoblastic Leukemia-Lymphoma - complications</subject><ispartof>The Journal of pediatrics, 1990-03, Vol.116 (3), p.355-359</ispartof><rights>1990 The C.V. Mosby Company</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c412t-1fa57bc688a278b0c8596b57c9675cd99651f025bd54dd2bee1ccc1ac57ec0363</citedby><cites>FETCH-LOGICAL-c412t-1fa57bc688a278b0c8596b57c9675cd99651f025bd54dd2bee1ccc1ac57ec0363</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0022347605828203$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3536,27903,27904,65309</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1689774$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Koch, William C.</creatorcontrib><creatorcontrib>Massey, Gita</creatorcontrib><creatorcontrib>Russell, Clifton E.</creatorcontrib><creatorcontrib>Adler, Stuart P.</creatorcontrib><title>Manifestations and treatment of human parvovirus B19 infection in immunocompromised patients</title><title>The Journal of pediatrics</title><addtitle>J Pediatr</addtitle><description>We diagnosed infections from human parvovirus B19 in three patients by using dot-blot hybrodization and a polymerase chain reaction to detect B19 DNA and using an enzyme immunoassay to detect IgG and IgM to B19. For 5 months a 5-year-old boy with acute lymphoblastic leukemia in remission had anemia without reticulocytes or bone marrow erythrocyte precursors. His serum lacked IgG and IgM to B19 but contained B19 DNA. He received gamma globulin intravenously (0.4 gm/kg/day for 5 days); his viremia promptly cleared and reticulocytosis developed. A 14-year-old boy with acute lymphoblastic leukemia in remission had fever, rash, neutropenia (&lt;300 leukocytes/mm 3), and a hemophagocytic syndrome lasting 3 weeks. His serum contained IgM to B19 and B19 DNA. Without therapy, IgG to B19 developed; although low levels of B19 DNA persisted, the leukocyte count returned to normal. In a 19-year-old patient with systemic lupus erythrmatosus and hemolytic anemia, an aplastic crisis lasted 2 weeks. Her serum lacked IgG and IgM to B19 but contained B19 DNA. Without therapy, IgG and IgM to B19 appeared, viremia diminished, and reticulocytosis occurred. These patients illustrate the varied manifestations of chronic B19 infections, the importance of DNA detection for diagnosis, and the possible efficacy of gamma globulin therapy</description><subject>Adolescent</subject><subject>Adult</subject><subject>Child, Preschool</subject><subject>DNA, Viral - analysis</subject><subject>Female</subject><subject>gamma-Globulins - therapeutic use</subject><subject>Humans</subject><subject>Immune Tolerance</subject><subject>Immunoenzyme Techniques</subject><subject>Lupus Erythematosus, Systemic - complications</subject><subject>Male</subject><subject>Parvoviridae Infections - diagnosis</subject><subject>Parvoviridae Infections - etiology</subject><subject>Parvoviridae Infections - immunology</subject><subject>Parvoviridae Infections - therapy</subject><subject>Polymerase Chain Reaction</subject><subject>Precursor Cell Lymphoblastic Leukemia-Lymphoma - complications</subject><issn>0022-3476</issn><issn>1097-6833</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1990</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkE9LxDAQxYMo67r6ERZ6Ej1UJ2mTtCfRxX-w4kG9CSFNUoxsmzVpF_z2pttFj55mYN6befNDaI7hAgNmly8AhKRZztkZ0POCFATSbA9NMZQ8ZUWW7aPpr-QQHYXwCQBlDjBBE8yKkvN8it6fZGtrEzrZWdeGRLY66byRXWPaLnF18tE3sk3W0m_cxvo-JDe4TGxbGzUYYpfYpulbp1yz9q6xweio7my0h2N0UMtVMCe7OkNvd7evi4d0-Xz_uLhepirHpEtxLSmvFCsKSXhRgSpoySrKVck4VbosGcU1EFppmmtNKmOwUgpLRblRkLFshk7HvTHBVx-fETGHMquVbI3rg-BxAyU8i0I6CpV3IXhTi7W3jfTfAoMYqIotVTEgE0DFlqoYfPPdgb5qjP5zjRjj_Gqcm_jlxhovgooElNHWR1BCO_vPhR-G8Iiz</recordid><startdate>19900301</startdate><enddate>19900301</enddate><creator>Koch, William C.</creator><creator>Massey, Gita</creator><creator>Russell, Clifton E.</creator><creator>Adler, Stuart P.</creator><general>Mosby, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19900301</creationdate><title>Manifestations and treatment of human parvovirus B19 infection in immunocompromised patients</title><author>Koch, William C. ; Massey, Gita ; Russell, Clifton E. ; Adler, Stuart P.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c412t-1fa57bc688a278b0c8596b57c9675cd99651f025bd54dd2bee1ccc1ac57ec0363</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1990</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Child, Preschool</topic><topic>DNA, Viral - analysis</topic><topic>Female</topic><topic>gamma-Globulins - therapeutic use</topic><topic>Humans</topic><topic>Immune Tolerance</topic><topic>Immunoenzyme Techniques</topic><topic>Lupus Erythematosus, Systemic - complications</topic><topic>Male</topic><topic>Parvoviridae Infections - diagnosis</topic><topic>Parvoviridae Infections - etiology</topic><topic>Parvoviridae Infections - immunology</topic><topic>Parvoviridae Infections - therapy</topic><topic>Polymerase Chain Reaction</topic><topic>Precursor Cell Lymphoblastic Leukemia-Lymphoma - complications</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Koch, William C.</creatorcontrib><creatorcontrib>Massey, Gita</creatorcontrib><creatorcontrib>Russell, Clifton E.</creatorcontrib><creatorcontrib>Adler, Stuart P.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of pediatrics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Koch, William C.</au><au>Massey, Gita</au><au>Russell, Clifton E.</au><au>Adler, Stuart P.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Manifestations and treatment of human parvovirus B19 infection in immunocompromised patients</atitle><jtitle>The Journal of pediatrics</jtitle><addtitle>J Pediatr</addtitle><date>1990-03-01</date><risdate>1990</risdate><volume>116</volume><issue>3</issue><spage>355</spage><epage>359</epage><pages>355-359</pages><issn>0022-3476</issn><eissn>1097-6833</eissn><abstract>We diagnosed infections from human parvovirus B19 in three patients by using dot-blot hybrodization and a polymerase chain reaction to detect B19 DNA and using an enzyme immunoassay to detect IgG and IgM to B19. For 5 months a 5-year-old boy with acute lymphoblastic leukemia in remission had anemia without reticulocytes or bone marrow erythrocyte precursors. His serum lacked IgG and IgM to B19 but contained B19 DNA. He received gamma globulin intravenously (0.4 gm/kg/day for 5 days); his viremia promptly cleared and reticulocytosis developed. A 14-year-old boy with acute lymphoblastic leukemia in remission had fever, rash, neutropenia (&lt;300 leukocytes/mm 3), and a hemophagocytic syndrome lasting 3 weeks. His serum contained IgM to B19 and B19 DNA. Without therapy, IgG to B19 developed; although low levels of B19 DNA persisted, the leukocyte count returned to normal. In a 19-year-old patient with systemic lupus erythrmatosus and hemolytic anemia, an aplastic crisis lasted 2 weeks. Her serum lacked IgG and IgM to B19 but contained B19 DNA. Without therapy, IgG and IgM to B19 appeared, viremia diminished, and reticulocytosis occurred. These patients illustrate the varied manifestations of chronic B19 infections, the importance of DNA detection for diagnosis, and the possible efficacy of gamma globulin therapy</abstract><cop>United States</cop><pub>Mosby, Inc</pub><pmid>1689774</pmid><doi>10.1016/S0022-3476(05)82820-3</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-3476
ispartof The Journal of pediatrics, 1990-03, Vol.116 (3), p.355-359
issn 0022-3476
1097-6833
language eng
recordid cdi_proquest_miscellaneous_79655273
source MEDLINE; Elsevier ScienceDirect Journals
subjects Adolescent
Adult
Child, Preschool
DNA, Viral - analysis
Female
gamma-Globulins - therapeutic use
Humans
Immune Tolerance
Immunoenzyme Techniques
Lupus Erythematosus, Systemic - complications
Male
Parvoviridae Infections - diagnosis
Parvoviridae Infections - etiology
Parvoviridae Infections - immunology
Parvoviridae Infections - therapy
Polymerase Chain Reaction
Precursor Cell Lymphoblastic Leukemia-Lymphoma - complications
title Manifestations and treatment of human parvovirus B19 infection in immunocompromised patients
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T04%3A54%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Manifestations%20and%20treatment%20of%20human%20parvovirus%20B19%20infection%20in%20immunocompromised%20patients&rft.jtitle=The%20Journal%20of%20pediatrics&rft.au=Koch,%20William%20C.&rft.date=1990-03-01&rft.volume=116&rft.issue=3&rft.spage=355&rft.epage=359&rft.pages=355-359&rft.issn=0022-3476&rft.eissn=1097-6833&rft_id=info:doi/10.1016/S0022-3476(05)82820-3&rft_dat=%3Cproquest_cross%3E79655273%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=79655273&rft_id=info:pmid/1689774&rft_els_id=S0022347605828203&rfr_iscdi=true